Another interesting finding to highlight is the presumed causal low-frequency protein-altering variant S1PR2:p.Y257C that we found to be associated with decreased LDL-C and a >50% reduction in the risk of myocardial infarction, without being associated with altered liver function or non-fasting blood glucose. The gene discussed is S1PR2; the disease is myocardial infarction.